rawfin.tv
AN2 Therapeutics Insider Plans $6.08 Million Stock Sale
MarketsstocksAI Generated

AN2 Therapeutics Insider Plans $6.08 Million Stock Sale

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

An insider at AN2 Therapeutics (ANTX) has filed a Form 144 notice, indicating an intention to sell 1,012,000 shares of common stock. The planned sale, valued at approximately $6.08 million, represents a notable insider disposition.

ANTXInsider TradingStock SalesBiotechnologyNasdaq

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks